Quarterly report pursuant to Section 13 or 15(d)

Long-Term Debt (Tables)

v3.5.0.2
Long-Term Debt (Tables)
9 Months Ended
Sep. 30, 2016
Debt Disclosure [Abstract]  
Aggregate future principal and final fee payments of interest bearing obligations

Aggregate future principal, final payment fees and discounts of the Company’s total interest bearing obligations as of September 30, 2016, are as follows (in thousands):

 

Three months ending December 31, 2016

 

$

2,252

 

Year ended 2017

 

 

14,809

 

Year ended 2018

 

 

18,085

 

Year ended 2019

 

 

 

Year ended 2020

 

 

15,748

 

 

 

 

50,894

 

Less: interest, final payment fee, discount and issuance cost

 

 

(5,675

)

 

 

 

45,219

 

Less: interest bearing obligations – current

 

 

(12,461

)

Interest bearing obligations – non-current

 

$

32,758

 

 

Interest expense and amortization of debt issuance costs

Amortization of debt issuance costs and discounts are included in interest expense. Interest expense in the condensed consolidated statements of comprehensive loss relates to the following debt instruments (in thousands):

 

 

 

Three  Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2016

 

 

2015

 

 

2016

 

 

2015

 

Hercules term loan

 

$

651

 

 

$

665

 

 

$

2,001

 

 

$

1,551

 

Servier loan

 

 

223

 

 

 

278

 

 

 

674

 

 

 

806

 

GECC term loan

 

 

 

 

 

 

 

 

 

 

 

548

 

Novartis note

 

 

104

 

 

 

84

 

 

 

299

 

 

 

243

 

Other

 

 

4

 

 

 

3

 

 

 

17

 

 

 

4

 

Total interest expense

 

$

982

 

 

$

1,030

 

 

$

2,991

 

 

$

3,152